Blue Horseshoe Stocks: BA, MA Updates & More

The Boeing Co. BA

We signaled some options ideas for Boeing on Wednesday morning, the BA Weekly $352.50-360 Calls. We were met with moderate-to-good intraday gains ranging from 74-188%, as we reported yesterday morning.

We have to swing back around and provide yet another update after the opportunities to profit really kicked into gear yesterday. The intraday moves and gains on the table were as follows:

$352.50 Calls – Range: 2.90-8.75 – Max Gain: 202%
$355 Calls – Range: 1.70-6.99  – Max Gain: 311%
$357.50 Calls – Range: 1.11-5.15 – Max Gain: 364%
$360 Calls – Range:  .50-4.00 – Max Gain: 700%


Mastercard, Inc. MA

We added ideas for the Mastercard chain as well in yesterday’s premarket report  with the MA Weekly $170-175 Calls. Those also turned out to provide the chances for some very nice intraday gains.

After the company beat solidly on earnings with rising revenues, the stock went on a run that was sufficient to create these moves on the day:

$170 Calls – Range: 2.00-5.00 – Max Gain: 150%
$172.50 Calls – Range: .80-2.70 – Max Gain: 238%
$175 Calls – Range:  .24-1.05 – Max Gain: 338%

_____

Fresh for Friday:
Sony Corp. SNE Weekly $51.50-53 Calls*

*Please do not attempt to trade weekly options on a Friday unless you are an expert level trader with disposable funds.


Extended Watchlist:
MARK, PTI, S, DECK, AIPT, TVIX, LBCC, IMUC, VKTX

Blue Horseshoe Stocks: Kicking Off the Short Week

INSYS Therapeutics, Inc. INSY

This morning we kick off the holiday shortened week, during a time of year that typically sees subdued activity for the markets as a whole, as people spend time with their families, and stay busy with holiday festivities.

We still strive to identify possible opportunities even in this environment, and the first thing to hit our scanner this morning was INSY. INSYS Therapeutics recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy.

The FDA, we’re learning today, has also granted Fast Track status to INSY for the ‘drug’ for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder. (View PR)

The stock registered its 52-week lows at the beginning of last month, and has been in a general uptrend since, but we’ll be looking for further bullish activity on the heels of this FDA news, both on the stock chart, and in the options chain as a secondary idea. For that, we’ll look to the INSY 01/19 $8 & $9 Calls for opportunities.


DelMar Pharmaceuticals, Inc. DMPI

Speaking of FDA Fast Track designations, we’re looking to DMPI this morning as well, which was granted the status by the FDA for its lead-product cancer treatment, VAL-083.

The chart itself was already set up as a possible bottom play, and despite gapping up considerably on this morning’s news, there is still room to the upside, including a sizable gap that’s been left on the chart since this past spring, the eventual filling of which would spell gains of more than 100% from the current PPS.


Extended Watchlist:
KLXI, EXXI, AEZS, SRAX, IMUC, NETE

Blue Horseshoe Stocks: AMRS, TTOO Recaps & More

 Cracker Barrel Old Country Store, Inc. CBRL

We were looking at a favorable setup on the CBRL chart along with a premarket earning beat in yesterday morning’s report, and we floated a couple of options ideas that worked out pretty well early on in the session.

We had the CBRL Weekly $150 & 151.50 Calls as well as the 10/20 $155 Calls on watch, and both our short -term and longer-term ideas provided excellent chances for multi-bag gains on the day.

The Weekly $150’s traded in a range from 1.01-4.00 (+296%), while the
$151.50’s ran from 1.10-2.79, gaining 154% intraday. Even the longer-term idea, the 10/20 $155’s more than doubled on the day, running 175% from 1.09-3.00.


Amyris, Inc. AMRS

We wanted to circle back for AMRS today to recap the past month of its performance on the chart. We put this play on bottom-watch on the morning of  August 15th, and as it turns out, our timing was pretty good. It was just a couple of sessions later when we observed a low of 1.86  in the stock, and it’s been mostly bullish moves since then.

Yesterday, AMRS hit a new high of 3.84, marking an overall increase of 106% in matter of just one month’s time. If the stock can manage to break its previous resistance around the 4.30 area, things could get really interesting.

______

Added Note:

T2 Biosystems, Inc. TTOO – In that same report from August 15th we were discussing the run we had seen from TTOO from 2.53 to its highs at the time just over $4. It too hit an impressive new high yesterday, at 6.99. That works out to a one month increase of 176%


Extended Watchlist:
ICNB, ONCI, TOPS, ALV, ALDX, IMUC,